Drug intelligence / Profile preview

zinc oxide + eugenol

Development stage
Phase 2
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Dental, Topical
01

Overview

Zinc oxide + eugenol (commonly abbreviated as ZOE) is a combination dental material formed by mixing powdered zinc oxide with liquid eugenol (derived from clove oil). The mixture undergoes an acid-base reaction to form a chelate called zinc eugenolate. ZOE is widely used in dentistry as a temporary filling material, dental cement for crowns and bridges, root canal sealer, impression material for dentures, and periodontal dressing. It is valued for its sedative effect on the dental pulp due to the anti-inflammatory and local anesthetic properties of eugenol. Zinc oxide provides antimicrobial action and acts as an obtundant (pain-relieving agent). While it has low mechanical strength compared to permanent cements or restorative materials, it is biocompatible when applied on dentin but can be cytotoxic at high concentrations or if placed directly on pulp tissue. Modified versions with additives like EBA or polymers have improved mechanical properties but retain the basic mechanism of action[1][2][3][5][7][8].

Other names
ZOEzinc oxide-eugenol cementzinc eugenolate
02

Targets

Bacterial Cell Membrane Proteins

Beyond the preview

Go deeper on zinc oxide + eugenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zinc oxide + eugenol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call